MAPK pathway activity plays a key role in PD‐L1 expression of lung adenocarcinoma cellsThijs S Stutvoet, Steven de Jong|The Journal of Pathology|2019Cited by 163
Differential modulation of the TRAIL receptors and the CD95 receptor in colon carcinoma cell linesCaroline M. M. van Geelen, Steven de Jong|British Journal of Cancer|2003Cited by 62
Low-dose triple drug combination targeting the PI3K/AKT/mTOR pathway and the MAPK pathway is an effective approach in ovarian clear cell carcinomaJoseph J. Caumanns, Steven de Jong|Cancer Letters|2019Cited by 58
Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell CarcinomaJoseph J. Caumanns, Steven de Jong|Clinical Cancer Research|2018Cited by 52
ADCC responses and blocking of EGFR-mediated signaling and cell growth by combining the anti-EGFR antibodies imgatuzumab and cetuximab in NSCLC cellsArjan Kol, Steven de Jong|Oncotarget|2017Cited by 31